index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

87

 

NOTICES

151

 

 

MOTS CLES

Intensive care Autoimmune diseases Endocrine toxicity Anxiété Biomarkers Epidemiology Bacterial rhinosinusitis Angiotensin receptor blockers Drug survival Immunotherapy Pregnancy Adalimumab CSK tyrosine-protein kinase Sipuleucel-T Apre-milast Pharmaco-Épidémiologie Ankylosing spondylitis Antimicrobial Stewardship Calcium channel blockers Ankylosing Placebo Amyloidosis Angiotensin-converting enzyme inhibitors Stability Pharmacoepidemiology Antimicrobial resistance Psoriasis Dermatology Antibiotic misuse Treatment Pharmacovigilance Immune-related adverse events Cardiomyopathy Autoimmunity Cardiotoxicity Anticancer drugs Etanercept Albinism Immune checkpoint inhibitors Access to care Meta-Analysis Ustekinumab Ethics Biologics Adolescent Biologic therapy Anti-Bacterial Agents Vigibase® Addiction Biologic Accelerometer Apremilast Glucocorticoids ASDAS Biological Therapy COVID-19 Aging BTK protein Management Spondyloarthritis Atopic dermatitis Auto-immune hepatitis Cancer Burden Arthritis Quality of life Drug reaction Antibiotic resistance Acute Myeloid Leukaemia AML Antimicrobiens Prostate cancer Anti-HCV Direct Acting Antivirals DAA Biosimilar Pharmaceuticals Sacroiliitis ArtThese Biological therapy Alcohol Méta-Analyse Cardio-oncology Arrhythmia Anti-TNF CTLA-4 Infliximab Anxiety Antimicrobials Graft-versus-host disease Abus d'antibiotiques Auto-Diagnostic Psoriatic arthritis Adverse side effects Primary adrenal insufficiency Bacterial Antibiotics Alitretinoin Beta-lactam antibiotics Biomédicaments Azathioprine Atrial fibrillation Axial spondyloarthritis Biologic drug

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS